Ensign Peak Advisors’s Boundless Bio BOLD Stock Holding History

Ensign Peak Advisors’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$400K	Sell	159,835 -27,665	-15%	-$42.6K	﹤0.01%	1061
2026 Q1	$206K	Hold	187,500	–	–	﹤0.01%	1297
2025 Q4	$225K	Hold	187,500	–	–	﹤0.01%	1261
2025 Q3	$231K	Hold	187,500	–	–	﹤0.01%	1628
2025 Q2	$189K	Hold	187,500	–	–	﹤0.01%	1682
2025 Q1	$283K	Hold	187,500	–	–	﹤0.01%	1646
2024 Q4	$544K	Hold	187,500	–	–	﹤0.01%	1581
2024 Q3	$651K	Sell	187,500 -177,186	-49%	-$642K	﹤0.01%	1536
2024 Q2	$1.41M	Sell	364,686 -10,314	-3%	-$98.6K	﹤0.01%	1065
2024 Q1	$5.34M	Buy	+375,000	New	+$5.34M	0.01%	622

Other funds holding BOLD

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Ensign Peak Advisors's BOLD Position: Q2 2026 in Review

Ensign Peak Advisors reduced its Boundless Bio (BOLD) stake by 15% in Q2 2026, selling an estimated $42.6K and leaving 159,835 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #1061.

Ensign Peak Advisors first reported a position in BOLD in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.34M in Q1 2024. 40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

Ensign Peak Advisors held 159,835 shares of Boundless Bio worth $400K as of Q2 2026.
Ensign Peak Advisors sold 27,665 Boundless Bio shares in Q2 2026, an estimated $42.6K.
Boundless Bio made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1061 holding.
Ensign Peak Advisors first reported a position in Boundless Bio in Q1 2024 and has held it in 10 quarters since.
Ensign Peak Advisors's Boundless Bio position peaked at $5.34M in Q1 2024.
40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.